title: Sulfhydryl reducing agents and shape regulation in human erythrocytes.
abstract: Metabolic crenation of red cells is reversible; on addition of nutrients, echinocytes recover the normal discoid shape. When the shape recovery takes place in the presence of reducing agents such as dithiothreitol (DTT), morphological change continues until the cells are stomatocytic. The degree of stomatocytosis varies, depending on the cell morphology when the nutrients and reducing agent are added. DTT has minimal effect on the shape of normal discocytes, but in its presence, mildly echinocytic cells become slightly cupped and advanced-stage echinocytes become severely stomatocytic. DTT must be present continuously for development and retention of stomatocytosis; echinocytes preincubated with or metabolically depleted in DTT do not become stomatocytic when supplemented in the absence of DTT, and DTT-induced stomatocytes revert to discocytes when the reducing agent is removed. DTT has no effect on adenosine triphosphate synthesis or equilibrium cell glutathione levels, and the induced stomatocytosis is not inhibited by excluding oxygen from cells during depletion. Spectrin phosphorylation and phosphate turnover are not affected by DTT. The echinocyte-to-discocyte transformation coincides with phosphorylation of membrane inner monolayer lipids (diacylglycerol to phosphatidic acid and phosphatidylinositol to phosphatidylinositol-4,5-bisphosphate). Overphosphorylation of these phospholipids is not responsible for the exaggerated shape recovery seen with reducing agents; phosphorylation of inner monolayer lipids proceeds identically in the presence and absence of DTT.
mesh_terms: D000255:Adenosine Triphosphate / Q000097:blood; D004075:Diglycerides / Q000378:metabolism; D004229:Dithiothreitol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004910:Erythrocyte Membrane / Q000166:cytology; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D005978:Glutathione / Q000097:blood; D006801:Humans; D010084:Oxidation-Reduction; D010716:Phosphatidylinositols / Q000378:metabolism; D010766:Phosphorylation; D013049:Spectrin / Q000378:metabolism; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D004075:Diglycerides; D010716:Phosphatidylinositols; D013439:Sulfhydryl Reagents; D013049:Spectrin; D000255:Adenosine Triphosphate; D005978:Glutathione; D004229:Dithiothreitol